Editorial: Immunophilins, protein chemistry and cell biology of a promising new class of drug targets – Part I

Guardado en:

Detalles Bibliográficos
Autor principal:	Galigniana, M.D.
Formato:	JOUR
Materias:	fk 506 binding protein glucocorticoid receptor immunophilin Rab protein steroid receptor ligand alternative medicine apoptosis cell division cytology degenerative disease drug protein binding drug targeting Editorial human Human immunodeficiency virus 1 infection immunosuppressive treatment ligand binding major depression mental disease nerve regeneration nonhuman pleiotropy priority journal signal transduction Streptomyces tsukubaensis animal antagonists and inhibitors chemistry drug development metabolism molecularly targeted therapy protein conformation Animals Drug Discovery Humans Immunophilins Ligands Molecular Targeted Therapy Protein Conformation
Acceso en línea:	http://hdl.handle.net/20.500.12110/paper_18744672_v9_n1_p3_Galigniana
Aporte de:	Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

id	todo:paper_18744672_v9_n1_p3_Galigniana
record_format	dspace
spelling	todo:paper_18744672_v9_n1_p3_Galigniana2023-10-03T16:34:07Z Editorial: Immunophilins, protein chemistry and cell biology of a promising new class of drug targets – Part I Galigniana, M.D. fk 506 binding protein glucocorticoid receptor immunophilin Rab protein steroid receptor immunophilin ligand alternative medicine apoptosis cell division cytology degenerative disease drug protein binding drug targeting Editorial human Human immunodeficiency virus 1 infection immunosuppressive treatment ligand binding major depression mental disease nerve regeneration nonhuman pleiotropy priority journal signal transduction Streptomyces tsukubaensis animal antagonists and inhibitors chemistry drug development metabolism molecularly targeted therapy protein conformation Animals Drug Discovery Humans Immunophilins Ligands Molecular Targeted Therapy Protein Conformation JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_18744672_v9_n1_p3_Galigniana
institution	Universidad de Buenos Aires
institution_str	I-28
repository_str	R-134
collection	Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic	fk 506 binding protein glucocorticoid receptor immunophilin Rab protein steroid receptor immunophilin ligand alternative medicine apoptosis cell division cytology degenerative disease drug protein binding drug targeting Editorial human Human immunodeficiency virus 1 infection immunosuppressive treatment ligand binding major depression mental disease nerve regeneration nonhuman pleiotropy priority journal signal transduction Streptomyces tsukubaensis animal antagonists and inhibitors chemistry drug development metabolism molecularly targeted therapy protein conformation Animals Drug Discovery Humans Immunophilins Ligands Molecular Targeted Therapy Protein Conformation
spellingShingle	fk 506 binding protein glucocorticoid receptor immunophilin Rab protein steroid receptor immunophilin ligand alternative medicine apoptosis cell division cytology degenerative disease drug protein binding drug targeting Editorial human Human immunodeficiency virus 1 infection immunosuppressive treatment ligand binding major depression mental disease nerve regeneration nonhuman pleiotropy priority journal signal transduction Streptomyces tsukubaensis animal antagonists and inhibitors chemistry drug development metabolism molecularly targeted therapy protein conformation Animals Drug Discovery Humans Immunophilins Ligands Molecular Targeted Therapy Protein Conformation Galigniana, M.D. Editorial: Immunophilins, protein chemistry and cell biology of a promising new class of drug targets – Part I
topic_facet	fk 506 binding protein glucocorticoid receptor immunophilin Rab protein steroid receptor immunophilin ligand alternative medicine apoptosis cell division cytology degenerative disease drug protein binding drug targeting Editorial human Human immunodeficiency virus 1 infection immunosuppressive treatment ligand binding major depression mental disease nerve regeneration nonhuman pleiotropy priority journal signal transduction Streptomyces tsukubaensis animal antagonists and inhibitors chemistry drug development metabolism molecularly targeted therapy protein conformation Animals Drug Discovery Humans Immunophilins Ligands Molecular Targeted Therapy Protein Conformation
format	JOUR
author	Galigniana, M.D.
author_facet	Galigniana, M.D.
author_sort	Galigniana, M.D.
title	Editorial: Immunophilins, protein chemistry and cell biology of a promising new class of drug targets – Part I
title_short	Editorial: Immunophilins, protein chemistry and cell biology of a promising new class of drug targets – Part I
title_full	Editorial: Immunophilins, protein chemistry and cell biology of a promising new class of drug targets – Part I
title_fullStr	Editorial: Immunophilins, protein chemistry and cell biology of a promising new class of drug targets – Part I
title_full_unstemmed	Editorial: Immunophilins, protein chemistry and cell biology of a promising new class of drug targets – Part I
title_sort	editorial: immunophilins, protein chemistry and cell biology of a promising new class of drug targets – part i
url	http://hdl.handle.net/20.500.12110/paper_18744672_v9_n1_p3_Galigniana
work_keys_str_mv	AT galignianamd editorialimmunophilinsproteinchemistryandcellbiologyofapromisingnewclassofdrugtargetsparti
_version_	1807320608048939008

Editorial: Immunophilins, protein chemistry and cell biology of a promising new class of drug targets – Part I

Ejemplares similares